Meibomian gland dysfunction, dropout and distress: emerging therapies

6Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

References Powered by Scopus

TFOS DEWS II pathophysiology report

1282Citations
N/AReaders
Get full text

The international workshop on meibomian gland dysfunction: Executive summary

795Citations
N/AReaders
Get full text

The international workshop on meibomian gland dysfunction: Report of the subcommittee on the epidemiology of, and associated risk factors for, MGD

486Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Efficacy and Safety evaluation of a single thermal pulsation system treatment (Lipiflow<sup>®</sup>) on meibomian gland dysfunction: a randomized controlled clinical trial

10Citations
N/AReaders
Get full text

Ductal Hyperkeratinization and Acinar Renewal Abnormality: New Concepts on Pathogenesis of Meibomian Gland Dysfunction

9Citations
N/AReaders
Get full text

Dry eye in systemic sclerosis patients: Novel methods to monitor disease activity

9Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Hassan, A., Balal, S., & Ahmad, S. (2020, September 1). Meibomian gland dysfunction, dropout and distress: emerging therapies. Eye (Basingstoke). Springer Nature. https://doi.org/10.1038/s41433-020-0865-5

Readers over time

‘20‘21‘22‘23‘24‘2502468

Readers' Seniority

Tooltip

Researcher 8

62%

PhD / Post grad / Masters / Doc 4

31%

Professor / Associate Prof. 1

8%

Readers' Discipline

Tooltip

Medicine and Dentistry 8

67%

Nursing and Health Professions 2

17%

Pharmacology, Toxicology and Pharmaceut... 1

8%

Engineering 1

8%

Save time finding and organizing research with Mendeley

Sign up for free
0